JP2023551873A5 - - Google Patents
Info
- Publication number
- JP2023551873A5 JP2023551873A5 JP2023533276A JP2023533276A JP2023551873A5 JP 2023551873 A5 JP2023551873 A5 JP 2023551873A5 JP 2023533276 A JP2023533276 A JP 2023533276A JP 2023533276 A JP2023533276 A JP 2023533276A JP 2023551873 A5 JP2023551873 A5 JP 2023551873A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- aav
- rna
- capsid protein
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063119977P | 2020-12-01 | 2020-12-01 | |
| US63/119,977 | 2020-12-01 | ||
| US202063130060P | 2020-12-23 | 2020-12-23 | |
| US63/130,060 | 2020-12-23 | ||
| PCT/US2021/061482 WO2022119974A1 (en) | 2020-12-01 | 2021-12-01 | Rna-targeting compositions and methods for treating cag repeat diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023551873A JP2023551873A (ja) | 2023-12-13 |
| JP2023551873A5 true JP2023551873A5 (https=) | 2024-10-29 |
Family
ID=79731103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023533276A Pending JP2023551873A (ja) | 2020-12-01 | 2021-12-01 | Ｃａｇリピート病を処置するためのｒｎａ標的化組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240000972A1 (https=) |
| EP (1) | EP4255470A1 (https=) |
| JP (1) | JP2023551873A (https=) |
| KR (1) | KR20230127221A9 (https=) |
| AU (1) | AU2021391643A1 (https=) |
| CA (1) | CA3200453A1 (https=) |
| WO (1) | WO2022119974A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3947700A4 (en) | 2019-04-01 | 2023-01-04 | Tenaya Therapeutics, Inc. | Adeno-associated virus with engineered capsid |
| BR112023006305A2 (pt) | 2020-10-09 | 2023-05-09 | Tenaya Therapeutics Inc | Métodos e composições de terapia gênica com placofilina-2 |
| JP2023551874A (ja) * | 2020-12-01 | 2023-12-13 | ロックアネイビオ， インコーポレイテッド | 筋強直性ジストロフィー１型を処置するためのｒｎａ標的化組成物および方法 |
| WO2022221278A1 (en) * | 2021-04-12 | 2022-10-20 | Locanabio, Inc. | Compositions and methods comprising hybrid promoters |
| CN119403933A (zh) * | 2022-06-21 | 2025-02-07 | 里格尔医疗股份有限公司 | 遗传调控元件及其用途 |
| CN119320798A (zh) * | 2023-07-17 | 2025-01-17 | 中国科学院上海营养与健康研究所 | 一种可用于筛选针对rna重复序列药物的报告系统 |
| TW202546236A (zh) * | 2024-01-16 | 2025-12-01 | 美商安斯泰來基因治療股份有限公司 | 用於治療第1型肌強直性營養不良之肌肉選擇性混合調節組合及其使用方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7056502B2 (en) | 2000-04-28 | 2006-06-06 | The Trustees Of The University Of Pennsylvania | Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids |
| ES2714007T3 (es) | 2007-04-09 | 2019-05-24 | Univ Florida | Composiciones de vectores rAAV que tienen proteínas de la cápside modificadas en tirosina y métodos para su uso |
| CN101895633A (zh) | 2010-07-14 | 2010-11-24 | 中兴通讯股份有限公司 | 一种移动终端及其解锁方法 |
| WO2012068627A1 (en) | 2010-11-24 | 2012-05-31 | The University Of Western Australia | Peptides for the specific binding of rna targets |
| DK2784157T3 (da) | 2011-10-21 | 2019-10-21 | Univ Kyushu Nat Univ Corp | Designfremgangsmåde til et rna-bindende protein under anvendelse af ppr-motiv og anvendelse deraf |
| US10330674B2 (en) | 2015-01-13 | 2019-06-25 | Massachusetts Institute Of Technology | Pumilio domain-based modular protein architecture for RNA binding |
| US10876101B2 (en) | 2017-03-28 | 2020-12-29 | Locanabio, Inc. | CRISPR-associated (Cas) protein |
| US10392616B2 (en) | 2017-06-30 | 2019-08-27 | Arbor Biotechnologies, Inc. | CRISPR RNA targeting enzymes and systems and uses thereof |
| US10476825B2 (en) | 2017-08-22 | 2019-11-12 | Salk Institue for Biological Studies | RNA targeting methods and compositions |
| KR20210058806A (ko) * | 2018-06-08 | 2021-05-24 | 로카나바이오 인크. | Rna 표적화 융합 단백질 조성물 및 사용 방법 |
| JP2023551874A (ja) * | 2020-12-01 | 2023-12-13 | ロックアネイビオ， インコーポレイテッド | 筋強直性ジストロフィー１型を処置するためのｒｎａ標的化組成物および方法 |
-
2021
- 2021-12-01 WO PCT/US2021/061482 patent/WO2022119974A1/en not_active Ceased
- 2021-12-01 CA CA3200453A patent/CA3200453A1/en active Pending
- 2021-12-01 AU AU2021391643A patent/AU2021391643A1/en active Pending
- 2021-12-01 KR KR1020237021515A patent/KR20230127221A9/ko active Pending
- 2021-12-01 EP EP21845128.4A patent/EP4255470A1/en active Pending
- 2021-12-01 US US18/039,813 patent/US20240000972A1/en active Pending
- 2021-12-01 JP JP2023533276A patent/JP2023551873A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023551873A5 (https=) | ||
| JP2023551874A5 (https=) | ||
| JP2022529631A5 (https=) | ||
| JP2020019772A5 (https=) | ||
| JP2022190081A5 (https=) | ||
| JP2022068181A5 (https=) | ||
| JP2021512649A5 (https=) | ||
| CA3216419A1 (en) | Tissue-targeted modified aav capsids and methods of use thereof | |
| JP2024099770A5 (https=) | ||
| JP2020519284A5 (https=) | ||
| JP2022529424A5 (https=) | ||
| JP2021523702A5 (https=) | ||
| JP2023537358A5 (https=) | ||
| JP2021534814A5 (https=) | ||
| JP2021522173A5 (https=) | ||
| JP2025500347A5 (https=) | ||
| JP2023515692A5 (https=) | ||
| JP2022525302A5 (https=) | ||
| CA3158518A1 (en) | Triple function adeno-associated virus (aav)vectors for the treatment of c9orf72 associated diseases | |
| JP2024517843A5 (https=) | ||
| JP2023537980A5 (https=) | ||
| JP2024508696A5 (https=) | ||
| JP2023059858A5 (https=) | ||
| JP2024530023A5 (https=) | ||
| JP2021534766A5 (https=) |